Novel Nonimmunological Forms of β-Cell Dysfunction: Diabetic Syndromes and Pathogenic MechanismsROBERTSON, R. Paul; AGUILAR-BRYAN, Lydia.Endocrine reviews. 2008, Vol 29, Num 3, issn 0163-769X, 129 p.Serial Issue

Glucolipotoxicity : Fuel Excess and β-Cell DysfunctionPOITOUT, Vincent; ROBERTSON, R. Paul.Endocrine reviews. 2008, Vol 29, Num 3, pp 351-366, issn 0163-769X, 16 p.Article

Neonatal Diabetes MellitusAGUILAR-BRYAN, Lydia; BRYAN, Joseph.Endocrine reviews. 2008, Vol 29, Num 3, pp 265-291, issn 0163-769X, 27 p.Article

Syndromes of Ketosis-Prone Diabetes MellitusBALASUBRAMANYAM, Ashok; NALINI, Ramaswami; HAMPE, Christiane S et al.Endocrine reviews. 2008, Vol 29, Num 3, pp 292-302, issn 0163-769X, 11 p.Article

Monogenic Diabetes in the Young, Pharmacogenetics and Relevance to Multifactorial Forms of Type 2 DiabetesVAXILLAIRE, Martine; FROGUEL, Philippe.Endocrine reviews. 2008, Vol 29, Num 3, pp 254-264, issn 0163-769X, 11 p.Article

Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer HypothesisHAATAJA, Leena; GURLO, Tatyana; HUANG, Chang J et al.Endocrine reviews. 2008, Vol 29, Num 3, pp 303-316, issn 0163-769X, 14 p.Article

Cytokines and β-Cell Biology : from Concept to Clinical TranslationDONATH, Marc Y; STØRLING, Joachim; BERCHTOLD, Lukas A et al.Endocrine reviews. 2008, Vol 29, Num 3, pp 334-350, issn 0163-769X, 17 p.Article

The Unfolded Protein Response : A Pathway That Links Insulin Demand with β-Cell Failure and DiabetesSCHEUNER, Donalyn; KAUFMAN, Randal J.Endocrine reviews. 2008, Vol 29, Num 3, pp 317-333, issn 0163-769X, 17 p.Article

Targeting β-Cell Mass in Type 2 Diabetes : Promise and Limitations of New Drugs Based on IncretinsSALEHI, Marzieh; AULINGER, Benedikt A; D'ALESSIO, David A et al.Endocrine reviews. 2008, Vol 29, Num 3, pp 367-379, issn 0163-769X, 13 p.Article